News
Archives
Lambda Therapeutic Research Expands Global Footprint in the U.S. by Acquiring Novum Pharmaceutical Research Services
Posted on by Andrea
Novum’s Fargo Clinic Hosted FDA Delegation at Workshop on Topical Skin Studies
Posted on by Andrea
Novum’s Chief Scientific Officer, Dr. Keith D. Gallicano, Presented at Beijing Industry Conference in November as Novum Makes Push in China
Posted on by Andrea
Scientists Advancing Affordable Medicines, Inc. Presented its 2018 Inaugural Workshop: Streamlining Generic Drug Development by Matching Reference Product Composition and Performance, In Vitro and In Vivo on October 18th & 19th, 2018 in Baltimore, MD. Novum’s Chief Scientific Officer Dr. Keith Gallicano is the co-founder of this organization.
Posted on by Andrea
The Association for Accessible Medicines (AAM) invited Dr. Keith D. Gallicano, Novum’s Chief Scientific Officer to be a panelist at the GRx +Biosims Conference on September 5-7, 2018 in Baltimore, MD.
Posted on by Andrea
Dr. Keith D. Gallicano, Novum’s Chief Scientific Officer published in March 2018 his 4th edition of the book chapter on Design and Data Analysis in Drug Interaction Studies.
Posted on by Andrea
Novum’s Scientific leadership published a paper on Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate.
Posted on by Andrea
Dr. Keith D. Gallicano was invited to present at the Global Bioequivalence Harmonization Initiative (GBHI) 3rd International Conference in Amsterdam on April 12-13, 2018.
Posted on by Andrea
Novum Conduct of Opioid Abuse Deterrent Studies
Posted on by Andrea